Crinetics Pharmaceuticals Inc’s filing revealed that its Chief Med and Dev Officer Pizzuti Dana unloaded Company’s shares for reported $0.78 million on Jan 03 ’25. In the deal valued at $52.09 per share,15,000 shares were sold. As a result of this transaction, Pizzuti Dana now holds 29,248 shares worth roughly $1.12 million.
Then, DANA J PIZZUTI bought 15,000 shares, generating $781,323 in total proceeds.
Before that, Struthers Richard Scott sold 10,000 shares. Crinetics Pharmaceuticals Inc shares valued at $575,700 were divested by the President & CEO at a price of $57.57 per share. As a result of the transaction, Struthers Richard Scott now holds 100,000 shares, worth roughly $3.82 million.
Jefferies upgraded its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Morgan Stanley began covering CRNX with “an Overweight” recommendation on January 16, 2024. Jefferies started covering the stock on December 21, 2023. It rated CRNX as “a Hold”.
Price Performance Review of CRNX
On Tuesday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock jump 0.03% to $38.22. Over the last five days, the stock has lost -1.39%. Crinetics Pharmaceuticals Inc shares have fallen nearly -25.25% since the year began. Nevertheless, the stocks have risen 2.60% over the past one year. While a 52-week high of $62.53 was reached on 01/03/25, a 52-week low of $35.51 was recorded on 01/14/25. SMA at 50 days reached $50.89, while 200 days put it at $50.64.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 37.68, which if violated will result in even more drops to 37.14. On the upside, there is a resistance level at 38.96. A further resistance level may holdings at 39.69. The Relative Strength Index (RSI) on the 14-day chart is 29.86, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.57%. Stochastics %K at 16.90% indicates the stock is a buying.
How much short interest is there in Crinetics Pharmaceuticals Inc?
A steep rise in short interest was recorded in Crinetics Pharmaceuticals Inc stocks on 2025-01-15, growing by 0.92 million shares to a total of 7.17 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 6.25 million shares. There was a rise of 12.79%, which implies that there is a positive sentiment for the stock.
